Shares of CVS Caremark Corp. continued climbing Friday
a day after it delivered a 2013 forecast and announced a dividend increase that left analysts raving about growth prospects for the drugstore chain and pharmacy benefits manager.
THE ANALYSIS: The company "lit up the room" at its investor day presentation with a bright outlook and plans to create more value for shareholders, BMO Capital analyst Dave Shove said in a research note, referring to the share repurchase plan and dividend increase.
Credit Suisse analyst Edward J. Kelly raised his price target on the stock to $55 from $50. He wrote in separate research note that the company's 2013 guidance was surprising, and it fueled a story that looked like it was "running out of gas in 2013."